Epizootic Hematopoietic Necrosis Virus

Overview and Taxonomy of Epizootic Hematopoietic Necrosis Virus

Epizootic Hematopoietic Necrosis Virus (EHNV) represents a singularly important pathogen within the Ranavirus genus of the family Iridoviridae, distinguished by its profound impact on both native and aquacultured fish and amphibian populations. As a notifiable pathogen listed by the World Organisation for Animal Health (WOAH), EHNV is recognized globally as a priority pathogen due to its capacity to cause devastating epizootics with high mortality rates, particularly in redfin perch (Perca fluviatilis) and rainbow trout (Oncorhynchus mykiss) [1, 5]. The virus is the etiological agent of epizootic hematopoietic necrosis (EHN), a systemic disease characterized by necrosis of the renal and splenic hematopoietic tissues, as well as hepatic and pancreatic degeneration. Despite its significant regulatory and economic importance, the biochemical and immunological characterization of EHNV has historically lagged behind that of other WOAH-listed fish viruses, a gap that recent proteomic and antigenic studies have begun to address [1]. Understanding the taxonomic position and biological attributes of EHNV is foundational to developing effective diagnostic, surveillance, and control strategies.

Taxonomic Hierarchy and Classification

EHNV is taxonomically assigned to the genus Ranavirus within the subfamily Alphairidovirinae of the family Iridoviridae. This family encompasses large, double-stranded DNA viruses with icosahedral morphology and a diameter of approximately 150–200 nm. The genus Ranavirus is notable for including pathogens that infect a wide range of poikilothermic vertebrates, including amphibians, reptiles, and fish. The placement of EHNV within this genus is supported by genomic architecture, major capsid protein (MCP) sequence homology, and phylogenetic analyses. The virus is considered the type species or a closely related variant within a complex of fish ranaviruses that includes the European catfish virus (ECV) and the doctor fish virus (DFV), although EHNV remains the most extensively characterized from a pathological standpoint. Critically, EHNV is distinct from other viruses causing hematopoietic necrosis in aquatic species, such as the infectious hematopoietic necrosis virus (IHNV), which is a rhabdovirus belonging to the Novirhabdovirus genus, and infectious hypodermal and hematopoietic necrosis virus (IHHNV), a parvovirus infecting penaeid shrimp [2, 3, 6]. This taxonomic distinction is essential for diagnostic specificity, as the clinical presentation and histopathological lesions, such as focal necrosis in hematopoietic tissues, can overlap with those caused by other agents, despite fundamentally different viral morphologies and replication strategies [5].

Molecular and Antigenic Characterization

At the molecular level, the EHNV virion is composed of a linear double-stranded DNA genome of approximately 127–130 kilobase pairs, encapsidated within an icosahedral capsid. The major capsid protein (MCP), with a molecular mass of approximately 50 kDa, constitutes the primary structural component of the virion and serves as the key target for molecular detection and phylogenetic classification [1]. Monini and Ruggeri (2002) provided foundational insights into the antigenic landscape of EHNV through the production of a panel of 124 murine monoclonal antibodies (MAbs) against live virus [1]. This work revealed that the immunodominant epitopes of EHNV are predominantly conformational in nature. Specifically, only three of twenty characterized MAbs were capable of immunoprecipitating the 50-kDa MCP from infected cell lysates, yet these same antibodies failed to recognize the denatured protein in Western blotting, underscoring the reliance of these epitopes on the native three-dimensional folding of the capsid [1]. Additionally, eight MAbs recognized peptides of approximately 15 kDa and five recognized 18 kDa peptides, suggesting the presence of additional immunogenic structural or non-structural proteins. Four additional MAbs demonstrated reactivity against infected cells and purified virions by ELISA but could not be mapped to any specific viral protein by standard biochemical techniques, further indicating the existence of labile, conformation-dependent antigenic determinants that may be critical for viral neutralization and immune recognition [1]. The absence of neutralizing activity among the generated MAbs, despite robust binding in ELISA, suggests that EHNV may employ mechanisms of immune evasion at the capsid surface or that neutralizing epitopes are particularly sensitive to conformational disruption during the production of hybridomas. These antigenic complexities have direct implications for the development of both antibody-based diagnostic tools and subunit vaccine designs.

Epidemiological and Host-Pathogen Context

From an epidemiological perspective, EHNV is notable for its narrow host range and high pathogenicity in susceptible species. The virus causes acute, systemic disease primarily in redfin perch and rainbow trout, with mortality rates often exceeding 90% in epizootic outbreaks. Sporadic infections have also been documented in other fish species, including Macquarie perch (Macquaria australasica) and silver perch (Bidyanus bidyanus), as well as in amphibian species such as the ornate burrowing frog (Limnodynastes ornatus). The virus is endemic to parts of Australia, where it has caused significant declines in wild redfin perch populations, and has been detected in Europe, particularly in France and Italy, although its distribution remains spatially constrained due to strict biosecurity measures. Surveillance efforts have been critical in assessing the virus’s geographical spread. For instance, Bautista et al. (2018) conducted a comprehensive PCR-based survey of 111 clinically diseased rainbow trout across multiple fish farms in the highlands of Peru, targeting the MCP gene using WOAH-recommended primers. Their study yielded no detection of EHNV DNA, indicating that the prevalence of the virus in that region was below 5% or that the observed mortality was attributable to other pathogens, such as Yersinia ruckeri and Aeromonas spp., which were isolated from all samples [4]. This negative finding is particularly valuable for establishing baseline prevalence data and reinforcing the importance of differential diagnosis between viral and bacterial etiologies in fish kills. The integration of molecular diagnostics with histopathological examination, as highlighted by Kurapati et al. (2026), remains the gold standard for confirming EHNV infection, as the gross and microscopic lesions, including multifocal necrosis of the kidney, spleen, and liver, can mimic those induced by other ranaviruses or bacterial septicemias [5].

The virus is transmitted horizontally through waterborne exposure, likely via shedding from infected fish and direct contact with lesions. Once established in a naïve population, the rapid replication cycle and the virus’s tropism for hematopoietic tissue lead to systemic failure and high mortality within days. The global significance of EHNV is underscored by its listing as a notifiable pathogen by WOAH, which mandates rigorous import controls and surveillance programs. The pathological cascade initiated by EHNV involves the targeted destruction of hematopoietic cells, leading to anemia, immunosuppression, and secondary infections. Understanding the precise antigenic and molecular architecture of the virus, particularly the role of the conformational epitopes of the MCP and the smaller immunogenic peptides, is paramount for the design of next-generation vaccines and point-of-care diagnostics that can be deployed in resource-limited aquaculture settings. The virus’s genomic stability relative to RNA viruses, such as IHNV (which exhibits a substitution rate of (1.39 \times 10^{-4}) substitutions/site/year), may influence the development of broadly protective vaccines, as the antigenic drift potential of a double-stranded DNA virus is theoretically lower [3]. Nonetheless, the host-specific virulence patterns and the existence of genotypic variants warrant continued molecular surveillance to anticipate potential shifts in pathogenicity or host range.

Molecular Pathogenesis of EHNV: Major Capsid Protein and Conformational Epitopes

The molecular pathogenesis of Epizootic Hematopoietic Necrosis Virus (EHNV) is fundamentally rooted in the structural and immunological properties of its major capsid protein (MCP), a 50-kDa polypeptide that constitutes the primary architectural component of the icosahedral virion. As a member of the genus Ranavirus within the family Iridoviridae, EHNV shares a conserved capsid architecture with other iridoviruses, yet exhibits unique antigenic features that govern its interaction with the host immune system and dictate its pathogenic potential. The MCP not only provides structural integrity to the virion but also serves as the principal target of the host humoral immune response, making it a critical determinant of viral pathogenesis and a focal point for diagnostic and vaccine development efforts. Understanding the conformational intricacies of the MCP and the nature of its epitopes is essential for elucidating the mechanisms by which EHNV evades immune recognition and establishes productive infection in susceptible salmonid and amphibian hosts.

Structural Organization and Biochemical Properties of the Major Capsid Protein

The EHNV MCP is a highly conserved protein among ranaviruses, with a molecular mass of approximately 50 kDa as determined by radioimmunoprecipitation assays [1]. This protein forms the outer capsid shell, which encapsulates the viral genome and associated enzymes necessary for early replication events. The MCP is synthesized during the late phase of viral replication and is assembled into the characteristic icosahedral capsid through a complex process involving scaffolding proteins and proteolytic cleavage events. The structural integrity of the MCP is maintained by extensive intra- and inter-molecular disulfide bonds, which confer stability to the capsid under varying environmental conditions, a feature critical for the virus’s persistence in aquatic environments. The World Organisation for Animal Health (WOAH) recognizes EHNV as a notifiable pathogen due to its significant economic impact on rainbow trout (Oncorhynchus mykiss) aquaculture and its potential to cause epizootics in wild fish populations [5].

Biochemical characterization of the MCP reveals that it is a glycoprotein, although the extent and functional significance of glycosylation remain incompletely understood. The protein’s primary sequence contains several conserved domains that are essential for capsid assembly and stability, including regions involved in inter-capsomer interactions. Cryo-electron microscopy studies of related ranaviruses suggest that the MCP arranges into trimeric capsomers, which further assemble into the icosahedral lattice. This hierarchical assembly process is highly dependent on the correct folding of the MCP, as misfolded proteins are rapidly degraded by cellular quality control mechanisms. The MCP’s ability to adopt multiple conformational states is central to its function, as these states dictate the exposure of antigenic epitopes and influence the virus’s susceptibility to neutralizing antibodies.

Conformational Epitopes and Antibody Recognition

A seminal study by Monini and Ruggeri (2002) provided the first comprehensive characterization of the antigenic determinants of EHNV using a panel of murine monoclonal antibodies (MAbs) generated against live virus [1]. This work revealed a striking dichotomy in the nature of epitopes recognized by the host immune system. Among 124 primary hybridoma cultures, only three MAbs were capable of immunoprecipitating the 50-kDa MCP from infected cell lysates, yet none of these MAbs recognized the MCP in Western blotting under denaturing conditions [1]. This observation is of paramount importance, as it demonstrates that the immunodominant epitopes on the MCP are strictly conformation-dependent. The failure of these MAbs to bind denatured MCP indicates that the linear amino acid sequence alone is insufficient for antibody recognition; rather, the native three-dimensional folding of the protein is absolutely required for epitope presentation.

The conformational nature of these epitopes has profound implications for viral pathogenesis and immune evasion. Conformational epitopes are typically formed by discontinuous amino acid residues that are brought into spatial proximity through protein folding. In the context of EHNV, these epitopes are likely located on the external surface of the capsid, where they are accessible to antibodies. The fact that the three MCP-specific MAbs did not exhibit neutralizing activity in vitro suggests that these particular epitopes may not be involved in critical steps of viral entry, such as receptor binding or membrane fusion [1]. Alternatively, it is possible that the MAbs recognize epitopes that are not essential for infectivity, or that the in vitro neutralization assay conditions were not optimal for detecting neutralizing activity. This absence of neutralizing MAbs is a notable finding, as it implies that the humoral immune response to EHNV may be dominated by non-neutralizing antibodies that target structural epitopes without directly interfering with viral entry.

Antigenic Complexity Beyond the Major Capsid Protein

The antigenic landscape of EHNV extends beyond the MCP, as demonstrated by the identification of MAbs recognizing smaller peptides of approximately 15 and 18 kDa [1]. These peptides likely represent minor capsid proteins or proteolytic cleavage products of larger structural proteins. The presence of multiple antigenic targets suggests that the host immune response is polyclonal, targeting a diverse array of viral proteins. Importantly, four MAbs could not be mapped to any specific viral protein, yet they specifically immunostained virus-infected cells and reacted with purified virions in ELISA [1]. These antibodies are also likely directed against conformation-dependent epitopes on the capsid surface, possibly involving quaternary structures formed by the assembly of multiple protein subunits. Such epitopes are notoriously difficult to characterize using conventional biochemical techniques, as they are destroyed by the denaturing conditions required for Western blotting.

The conformational dependence of EHNV epitopes has significant implications for vaccine design. Subunit vaccines based on recombinant MCP expressed in bacterial systems may fail to elicit protective immune responses if the recombinant protein does not adopt the correct native conformation. This is a well-recognized challenge in iridovirus vaccinology, as the MCP requires proper glycosylation and disulfide bond formation to present authentic conformational epitopes. The use of virus-like particles (VLPs) or other particulate antigen delivery systems may be necessary to preserve the conformational integrity of the MCP and induce a robust antibody response. The WOAH’s guidelines for EHNV surveillance emphasize the importance of using native viral antigens in diagnostic assays, as denatured antigens may yield false-negative results due to the loss of conformational epitopes [5].

Molecular Mechanisms of Immune Evasion and Pathogenesis

The reliance on conformational epitopes may represent an immune evasion strategy employed by EHNV. By presenting epitopes that are sensitive to denaturation, the virus may limit the effectiveness of antibody-mediated neutralization, particularly in the context of the host’s inflammatory response, which can alter the redox state of the cellular environment and potentially disrupt capsid conformation. Furthermore, the absence of neutralizing antibodies in the MAb panel suggests that EHNV may have evolved to minimize the exposure of conserved, functionally critical epitopes on its surface. This is analogous to the strategy employed by other icosahedral viruses, such as picornaviruses, where neutralizing epitopes are often located in deep canyons or depressions on the capsid surface, rendering them inaccessible to antibodies.

The pathogenesis of EHNV is intimately linked to the interaction between the MCP and host cellular receptors. Although the specific receptor for EHNV has not been identified, studies on related ranaviruses suggest that the MCP mediates attachment to host cells via interactions with integrins or other cell surface molecules. The conformational state of the MCP is likely to influence receptor binding affinity, as structural rearrangements may be required to expose receptor-binding domains. Once internalized, the viral capsid undergoes uncoating, a process that is also dependent on conformational changes in the MCP triggered by the acidic environment of the endosome. The ability of the MCP to undergo these structural transitions is a key determinant of viral infectivity and tissue tropism.

Diagnostic and Therapeutic Implications

The conformational nature of EHNV epitopes has direct implications for the development of diagnostic tools. Serological assays based on recombinant MCP must ensure that the antigen is presented in its native conformation to accurately detect antibodies from infected fish. The use of whole-virus ELISA or native MCP purified from infected cell cultures is recommended for serosurveillance, as these preparations preserve conformational epitopes [1]. The WOAH’s diagnostic manual for EHNV emphasizes the use of virus isolation in cell culture followed by immunofluorescence or PCR confirmation, as serological assays are not yet standardized for routine surveillance [5].

The identification of conformation-dependent epitopes also opens avenues for therapeutic intervention. Monoclonal antibodies that recognize these epitopes could be engineered for passive immunotherapy, particularly in valuable broodstock or endangered amphibian populations. However, the lack of neutralizing activity in the currently available MAbs suggests that additional screening efforts are needed to identify antibodies that can block viral entry. Structural studies, such as X-ray crystallography or cryo-electron microscopy of the EHNV capsid in complex with Fab fragments, would provide atomic-level insights into the architecture of conformational epitopes and guide the design of immunogens that elicit neutralizing antibodies.

In conclusion, the molecular pathogenesis of EHNV is profoundly influenced by the structural and antigenic properties of its major capsid protein. The MCP’s conformation-dependent epitopes represent a double-edged sword: they are essential for capsid integrity and viral infectivity, yet they also pose significant challenges for vaccine development and serological diagnosis. The absence of neutralizing epitopes among the immunodominant sites suggests that EHNV has evolved sophisticated mechanisms to evade antibody-mediated neutralization, likely contributing to its persistence in aquatic ecosystems. Future research should focus on high-resolution structural characterization of the EHNV capsid, identification of the cellular receptor, and elucidation of the conformational changes that accompany viral entry. Such studies will be instrumental in developing effective vaccines and antiviral strategies against this economically devastating pathogen.

Epidemiology and Host Range of EHNV in Aquaculture and Wild Populations

Epizootic Hematopoietic Necrosis Virus (EHNV), a member of the genus Ranavirus within the family Iridoviridae, represents a significant viral pathogen for both cultured and wild finfish populations, primarily within the Australasian region. Despite its relatively restricted known geographic distribution compared to other aquatic rhabdoviruses or parvoviruses, EHNV holds considerable regulatory importance, being listed by the World Organisation for Animal Health (WOAH) as a notifiable pathogen due to its high pathogenicity and potential for international spread through trade in live fish and germplasm [5]. The epidemiology and host range of EHNV are characterized by a complex interplay of viral virulence determinants, host species susceptibility, environmental influences, and anthropogenic translocation events. A deep and exhaustive examination of these factors is critical for understanding the virus’s epizootiology, implementing effective surveillance programs, and designing evidence-based control strategies for aquaculture operations and conservation efforts in wild ecosystems.

Global Distribution and Focal Endemism

The known geographic distribution of EHNV is conspicuously focal, with the virus primarily considered endemic to Australia, where it was first isolated in the mid-1980s from farmed redfin perch (Perca fluviatilis) experiencing mass mortality events. Subsequent surveillance and diagnostic investigations have confirmed the presence of EHNV across several states in southeastern Australia, particularly in Victoria, New South Wales, and the Australian Capital Territory. The virus has been consistently detected in both aquaculture facilities, especially those culturing rainbow trout (Oncorhynchus mykiss), and in wild freshwater fish populations, notably redfin perch in river systems and impoundments. The spread of EHNV within Australia has been linked to both the translocation of infected fish for stocking and aquaculture purposes and the natural movement of wild carrier fish. Despite extensive surveillance efforts, EHNV has not been reported from other continents, including North America, Europe, or Asia, where other ranaviruses are endemic. This suggests that the virus may have originated in Australia, possibly from a yet-unidentified native reservoir host, or was introduced historically and subsequently became established. The absence of EHNV in a 2018 survey of diseased rainbow trout in fish farms across the highlands of Peru, using WOAH-recommended PCR targeting the major capsid protein (MCP) gene, reinforces the hypothesis that the virus remains geographically confined to Australia [4]. This survey, which examined 111 fish from three regions, found no EHNV DNA, indicating a prevalence of less than 5% or true absence, and attributed mortality to bacterial pathogens such as Yersinia ruckeri and Aeromonas spp. [4]. The absence of EHNV in South America, despite significant global trade in salmonid eggs and live fish, underscores the effectiveness of existing biosecurity protocols or, alternatively, the lack of suitable ecological niches or susceptible host populations.

Host Range and Species Susceptibility

The host range of EHNV is relatively narrow but includes both native Australian species and introduced salmonids, which are the mainstay of cold-water aquaculture. The most notorious host is the redfin perch (Perca fluviatilis), an introduced species in Australia that is exquisitely sensitive to EHNV infection. Epizootics in redfin perch are characterized by explosive mortality, particularly in juvenile fish, with cumulative mortality often exceeding 90-100%. This high susceptibility renders redfin perch a sentinel species for EHNV activity in freshwater ecosystems. The virus has also been isolated from naturally infected farmed rainbow trout (Oncorhynchus mykiss), where it causes significant but often less catastrophic mortality compared to redfin perch. Atlantic salmon (Salmo salar) have also been experimentally infected and are considered susceptible, though natural outbreaks are less frequently reported. Notably, EHNV has been demonstrated to infect amphibians, expanding its host range beyond fish [1]. Experimental infections have shown that the virus can replicate in several amphibian species, including the common frog (Rana temporaria) and the cane toad (Rhinella marina), causing lethal disease. This ability to cross the vertebrate class boundary from fish to amphibians is a hallmark of some ranaviruses and has profound implications for conservation biology, as EHNV could potentially impact declining amphibian populations in Australian ecosystems. The antigenic characterization of EHNV, as demonstrated by the production of murine monoclonal antibodies (MAbs), has revealed that the major capsid protein (MCP) of approximately 50 kDa is a primary antigenic target, though many MAbs recognize conformation-dependent epitopes on the capsid surface [1]. This suggests that neutralizing antibody responses in hosts may be structurally complex, potentially influencing host susceptibility and the efficacy of humoral immunity across different species.

Ecological and Environmental Drivers of Epizootics

The epidemiology of EHNV is profoundly influenced by abiotic environmental factors, most notably water temperature. Experimental and field observations consistently demonstrate that epizootics occur predominantly during the austral spring and summer months when water temperatures rise above 15°C. The optimal temperature range for viral replication in susceptible fish hosts and in cell culture is between 15°C and 22°C. At lower temperatures (e.g., below 10°C), viral replication is severely curtailed, and clinical disease rarely manifests, even in highly susceptible species like redfin perch. This temperature-dependent pathogenesis creates a seasonal pattern of disease emergence, with the virus persisting in carrier fish or environmental reservoirs during colder periods and reactivating when thermal conditions become favorable. Water quality parameters, including dissolved oxygen levels, pH, and the presence of organic matter, may also modulate host stress and susceptibility, but these factors are less well-defined for EHNV compared to temperature. The virus is relatively robust in the aquatic environment, remaining infectious for extended periods in water, particularly at lower temperatures and in the absence of direct sunlight. This environmental persistence facilitates indirect transmission between susceptible hosts, complicating disease control in both aquaculture ponds and natural water bodies. Furthermore, the presence of scavengers, piscivorous birds, and other wildlife that feed on infected carcasses may contribute to mechanical dissemination of the virus over considerable distances.

Transmission Dynamics in Aquaculture and Wild Populations

In aquaculture settings, EHNV is primarily transmitted horizontally via the waterborne route, with the virus shed in high concentrations in the urine, feces, and gill exudates of infected fish. The high stocking densities typical of intensive salmonid and perch culture facilitate rapid viral spread through a facility, leading to high morbidity and mortality within days to weeks. Cohabitation of infected and naïve fish is the most efficient experimental method for reproducing the disease, as evidenced by multiple challenge studies. Fomites, such as nets, tanks, and aeration equipment, can also serve as vehicles for mechanical transmission if not properly disinfected. Vertical transmission (from broodstock to progeny via gametes) has not been conclusively demonstrated for EHNV, though the possibility of egg-associated transmission cannot be entirely discounted and remains an area requiring further research. In wild populations, transmission dynamics are more complex and influenced by host density, spatial distribution, and the presence of carrier species. The high virulence of EHNV in redfin perch often leads to population crashes that can temporarily reduce local transmission, but the virus persists in less susceptible species, such as rainbow trout, which may act as long-term reservoirs. The role of predatory or scavenging birds in the long-distance dissemination of EHNV is suspected but not fully quantified. The detection of EHNV in apparently healthy wild fish suggests a carrier state exists, where fish harbor subclinical infections and intermittently shed virus, maintaining the enzootic cycle. The antigenic complexity of the virus, with multiple conformation-dependent epitopes, may contribute to immune evasion and the establishment of persistent infections in certain hosts [1].

Regulatory Significance and Surveillance Challenges

The listing of EHNV as a notifiable pathogen by WOAH underscores its importance for international trade in aquatic animals and their products [5]. The OIE Aquatic Animal Health Code requires member countries to report any detection of EHNV to prevent its spread to new geographic regions. The primary surveillance tools for EHNV include virus isolation in cell culture (e.g., CHSE-214, EPC cells) followed by confirmation with PCR targeting the MCP gene, or direct PCR from tissue samples. The development of standardized, sensitive diagnostic assays is critical for effective surveillance. As noted in a comprehensive review of viral diseases in aquaculture, integrated approaches combining histopathological examination of hematopoietic tissues (spleen, kidney) with molecular diagnostics are essential for accurately diagnosing EHNV and differentiating it from other ranaviruses and similar viral pathogens [5]. However, challenges remain, including the need for harmonized lesion scoring systems and standardized sampling protocols across different laboratories and countries [5]. Surveillance in wild populations is particularly challenging due to difficulties in accessing remote water bodies, the logistical constraints of sampling sufficient numbers of fish, and the requirement for lethal sampling to obtain appropriate tissues (kidney, spleen, liver) for analysis. The negative survey from Peru highlights that even systematic sampling of clinically diseased fish in areas with no prior history of EHNV can provide valuable baseline data, supporting the disease-free status of a region and facilitating safe international trade [4].

Implications for Conservation and Aquaculture Biosecurity

The dual impact of EHNV on both aquaculture productivity and wild fish conservation necessitates a proactive management approach. In aquaculture, biosecurity measures should focus on preventing viral entry through the use of certified virus-free stock, disinfection of incoming water sources (e.g., UV irradiation or ozonation), implementation of quarantine protocols for new fish introductions, and strict hygiene practices for equipment and personnel. Vaccination against EHNV is not currently practiced on a commercial scale, largely due to the logistical challenges of delivering vaccines to large numbers of fish in a cost-effective manner and the limited market within the virus’s endemic range. Research into inactivated and recombinant vaccines has been conducted, but none have achieved widespread field application. In wild populations, management is more passive, relying on the natural temperature-dependent epidemiology and the capacity of some host species to develop resistance. The introduction of EHNV into naïve wild populations, particularly those containing threatened or endangered fish or amphibian species, could be catastrophic. Therefore, preventing the translocation of infected fish for stocking, aquaculture, or the aquarium trade is paramount. The ability of EHNV to infect amphibians introduces an additional layer of conservation concern, as ranaviruses have been implicated in global amphibian declines. Continued surveillance of both fish and amphibian populations in areas where EHNV is endemic, coupled with strict import controls in disease-free regions, remains the cornerstone of preventing the further geographic expansion of this significant aquatic pathogen.

Clinical Manifestations and Histopathological Features of EHNV Infection

Epizootic Hematopoietic Necrosis Virus (EHNV) induces a systemic, highly lethal disease in susceptible fish hosts, predominantly juvenile rainbow trout (Oncorhynchus mykiss) and redfin perch (Perca fluviatilis), with occasional reports in other species such as Atlantic salmon (Salmo salar) and Macquarie perch (Macquaria australasica). As a member of the genus Ranavirus within the family Iridoviridae, EHNV is classified as a notifiable pathogen by the World Organisation for Animal Health (WOAH) due to its profound economic impact on aquaculture and its threat to wild fish populations. The clinical course of EHNV infection is acute to peracute, with mortality rates often exceeding 90% in naïve populations, particularly during epizootic outbreaks in fry and fingerling stages. Understanding the nuanced clinical manifestations and the underlying histopathological disruptions is critical for accurate diagnosis, timely intervention, and effective disease management.

Clinical Manifestations

The incubation period for EHNV is temperature-dependent, typically ranging from 5 to 14 days at optimal water temperatures (12–18°C), with higher temperatures accelerating disease progression. The onset is abrupt, and infected fish often exhibit a rapid transition from apparently normal behavior to severe morbidity. The earliest clinical signs are nonspecific and include progressive lethargy, disorientation, and loss of equilibrium, which may manifest as spiral swimming or erratic, uncoordinated movements. Affected fish frequently congregate at the water surface or at the outflow of tanks, displaying gasping behavior indicative of respiratory distress. Anorexia is a consistent feature, leading to rapid emaciation in subacute cases.

Externally, the most striking and diagnostically suggestive clinical sign is the development of multifocal to coalescing hemorrhages. These hemorrhages are most pronounced in the skin, particularly on the ventral surface of the body, around the opercula, at the base of the fins, and on the flanks [5]. The hemorrhagic diathesis reflects underlying vascular damage and a severe consumptive coagulopathy. Pale gills, resulting from profound anemia secondary to hematopoietic necrosis, are a common observation. Exophthalmos (pop-eye) and abdominal distension due to ascites are frequently reported. In some chronic or recovering cases, melanosis (darkening of the skin) may be noted, though this is less common than in some other systemic viral infections.

Internally, the gross pathological changes are dominated by the dramatic enlargement and softening of the spleen and the anterior (head) kidney. These organs are the primary hematopoietic tissues in teleosts and are the principal targets of EHNV. The spleen is typically markedly enlarged (splenomegaly), turgid, and friable, often exhibiting a mottled, dark red to black appearance due to extensive hemorrhage and necrosis. The anterior kidney is similarly enlarged and hemorrhagic, losing its normal, firm texture and becoming pulpy. The liver may be pale, friable, and occasionally hemorrhagic. Ascitic fluid, often serosanguinous, is commonly present within the peritoneal cavity. The intestinal tract is frequently devoid of food and may contain a yellowish or blood-tinged fluid, indicative of enteritis.

Histopathological Features

The histopathological hallmark of EHNV infection is a severe, multifocal to diffuse coagulative necrosis affecting the principal hematopoietic organs: the renal interstitium and the splenic parenchyma. In the anterior kidney, the interstitial hematopoietic tissue, comprising precursor cells of erythroid, myeloid, and lymphoid lineages, undergoes extensive liquefactive necrosis [5]. The normal architecture is obliterated by large, confluent areas of cellular debris, pyknotic and karyorrhectic nuclei, and eosinophilic granular material. Remaining viable hematopoietic cells often exhibit cytomegaly, with nuclei showing peripherally marginated chromatin and prominent, often basophilic, intranuclear inclusion bodies. These inclusion bodies are a characteristic feature of iridovirus infections, though they are not universally observed in all cases and require careful histological examination.

The spleen exhibits a mirror image of this destruction. The ellipsoids and the surrounding red pulp, sites of intense hematopoietic and reticuloendothelial activity, undergo extensive necrosis. Lymphoid depletion within the splenic white pulp is a consistent finding, reflecting the profound immunosuppression induced by the virus [5]. The splenic sinuses are frequently congested with lysed erythrocytes and cellular debris, contributing to the grossly observed splenomegaly and hemorrhagic appearance.

The liver is another major site of pathology, though the lesions are often more variable in intensity. Hepatocellular necrosis is typically multifocal, ranging from small, scattered foci of single-cell necrosis to larger, confluent regions of coagulative necrosis. Affected hepatocytes show increased eosinophilia, nuclear pyknosis, and cytoplasmic vacuolation. The hepatic sinusoids are frequently dilated and congested. In some instances, intranuclear inclusion bodies can be identified within degenerating hepatocytes, although they are less numerous than in hematopoietic tissues.

In the gills, histopathological changes are secondary to the severe anemia and circulatory disturbance. Lamellar epithelial hyperplasia and hypertrophy are common, leading to fusion of adjacent secondary lamellae and a reduction in the functional respiratory surface area [5]. Hemorrhage within the gill interstitium is also a frequent finding. These changes correlate with the observed respiratory distress and hypoxic mortality.

The hematopoietic necrosis extends less consistently but still significantly to other sites of extramedullary hematopoiesis, including the intestinal lamina propria and the pancreatic interstitium. The kidney tubules and glomeruli are often spared from direct viral cytopathology, although they may show secondary changes such as tubular dilatation and proteinaceous cast formation due to renal ischemia. The brain may show perivascular cuffing and focal gliosis in some cases, although central nervous system involvement is not a dominant feature.

The pathogenesis of these lesions is driven by the virus's profound tropism for mitotically active hematopoietic cells. The cytopathic effect is lytic, leading to the rapid destruction of these cells and the release of progeny virions. The resulting pancytopenia, particularly erythrocytopenia and thrombocytopenia, underpins the severe anemia and hemorrhagic diathesis. The massive release of intracellular contents and pro-inflammatory mediators contributes to a systemic inflammatory response syndrome, culminating in multiorgan failure and death. The histopathological presentation, while not entirely pathognomonic, is highly characteristic and, when combined with the clinical picture and appropriate molecular diagnostics (e.g., PCR targeting the major capsid protein gene), provides a robust framework for confirming EHNV infection.

Diagnostic Methods for EHNV: Serological Assays and Molecular Detection

The accurate and timely diagnosis of Epizootic Hematopoietic Necrosis Virus (EHNV) is a cornerstone of effective disease surveillance, quarantine enforcement, and the implementation of control strategies within the aquaculture industry. As a notifiable pathogen listed by the World Organisation for Animal Health (WOAH), the deployment of diagnostic tools that are both highly sensitive and specific is paramount for managing outbreaks and preventing the international spread of this iridovirus. Diagnostic approaches for EHNV have evolved from classical virological and serological techniques towards highly sensitive molecular assays, though each modality presents unique advantages and inherent limitations that must be understood for proper application in both clinical and research settings. The development of these methods has been significantly informed by the fundamental biology of the virus, particularly the immunodominance of its major capsid protein (MCP) and the conformation-dependent nature of its key epitopes [1, 5].

Serological Assays for EHNV

The humoral immune response to EHNV infection is a critical target for diagnostic development, yet it has presented significant challenges to researchers. Early efforts to develop robust antibody-based detection systems revealed the complex antigenic landscape of the virus. A landmark study by Monini and Ruggeri [1] utilized a panel of murine monoclonal antibodies (MAbs) produced following parenteral inoculation with live EHNV. This work was instrumental in characterizing the principal antigenic determinants of the virus. Out of 124 primary hybridoma cultures that produced antibodies reactive with EHNV by enzyme-linked immunosorbent assay (ELISA), a striking observation was made: no neutralizing monoclonal antibodies were detected [1]. This finding has profound implications for both the understanding of viral pathogenesis and the design of serological diagnostics, suggesting that the primary humoral response may not be directed towards epitopes that block viral entry, or that the neutralizing epitopes are highly conformational and poorly immunogenic in the mouse model.

Further characterization of a subset of 20 randomly chosen hybridoma cultures via Western blotting, radioimmunoprecipitation (RIP), and immunostaining of infected cells elucidated the specific protein targets of these MAbs. Critically, only three of the MAbs immunoprecipitated the 50-kDa major capsid protein (MCP) from infected cell lysates, yet these same antibodies failed to recognize the MCP in Western blotting under denaturing conditions [1]. This is a classic indicator of conformation-dependent epitopes; the structural integrity of the MCP is essential for antibody recognition, which is lost upon the denaturing conditions of Western blotting. This dependency on native conformation must be considered when designing ELISAs or immunohistochemistry protocols where antigen integrity is paramount. In addition to the MCP-directed antibodies, eight further MAbs recognized a peptide of approximately 15 kDa, and five recognized an 18 kDa peptide. Intriguingly, four antibodies could not be mapped to any known viral protein, yet they specifically immunostained infected cells and reacted with purified virions in ELISA, again strongly suggesting they target conformation-dependent structures on the capsid surface [1].

The practical implications for serological screening are significant. While ELISAs using these MAbs have been developed for the detection of viral antigen directly from tissue homogenates or cell culture supernatants, the lack of neutralizing antibodies in the panel highlights a limitation for assays intended to detect a protective immune response in exposed fish. Furthermore, the reliance on MAbs that recognize conformation-dependent epitopes means that serological tests require precise control over antigen preparation and assay conditions (e.g., pH, detergents) to maintain epitope integrity. These constraints have historically made serology less attractive than molecular methods for routine surveillance, as the preparation of high-quality viral antigen for ELISA requires cell culture infrastructure and expertise that may not be available in all diagnostic laboratories. However, antigen-capture ELISAs remain useful for confirming the presence of the virus in clinical samples during acute outbreaks, providing a complementary approach to molecular detection that can detect whole virions or viral proteins which may be present even in the presence of PCR inhibitors or degraded nucleic acid.

Molecular Detection Methods for EHNV

The advent of molecular diagnostics has revolutionized the detection of aquatic viruses, including EHNV. The WOAH-manual standard for EHNV detection is based on conventional polymerase chain reaction (PCR) targeting a conserved region of the MCP gene [4]. This approach offers a significant improvement in speed and sensitivity over traditional cell culture isolation, which can take days and requires permissive cell lines. The selection of the MCP gene as the amplification target is biologically sound; it is a highly conserved region essential for viral structure and function, reducing the probability of false negatives due to sequence variation across isolates.

The application of this standard PCR was demonstrated in a surveillance study of rainbow trout (Oncorhynchus mykiss) in the highlands of Peru [4]. Researchers extracted DNA from pooled tissue samples (liver, spleen, and anterior kidney) using a Trizol-based method followed by purification with silica membranes (PureLink Genomic DNA kit). The PCR was performed using the MCP-1 primers as prescribed by the WOAH methodology, and confirmation was sought using a commercial kit (VetPCR™ EHNV Detection) [4]. While the study yielded negative results, indicating that EHNV was not a causative agent of mortality in the sampled farms at a prevalence greater than 5%, the methodology itself serves as a robust template for diagnostic workflows. This approach underscores the critical importance of internal controls and adherence to standardized protocols to avoid the amplification of non-specific products or the reporting of false negatives from degraded samples.

The evolution of molecular diagnostics has moved beyond conventional end-point PCR. Real-time quantitative PCR (qPCR) assays offer the dual advantages of quantification and increased sensitivity through the use of fluorescent probes (e.g., TaqMan). This allows for the real-time monitoring of amplification and eliminates the need for post-PCR processing, thus reducing the risk of carryover contamination. For EHNV, a universal reverse transcription real-time PCR (RT-rPCR) targeting the nucleocapsid (N) protein gene has been validated for the detection of North American genogroups, demonstrating that genogroup discrimination is also possible through careful probe design [9]. This is diagnostically crucial, as different genogroups (e.g., U, M, L, E, J) may vary in virulence and host range, and the epidemiology of these variants is of great interest for disease management [9]. The diagnostic sensitivity (DSe >94%) and specificity (DSp >97%) of such assays, when compared to cell culture, are exceptionally high, making RT-rPCR the gold standard for both active surveillance and confirmatory diagnosis [9].

Beyond PCR-based methods, isothermal amplification technologies such as Loop-mediated Isothermal Amplification (LAMP) have been investigated for similar viral pathogens and are conceptually applicable to EHNV. These methods, which amplify DNA at a constant temperature using a set of four to six primers, are particularly attractive for point-of-care testing or field deployment due to their rapidity and reduced need for expensive thermocyclers. While LAMP has been primarily developed and validated for the shrimp pathogen Infectious Hypodermal and Hematopoietic Necrosis Virus (IHHNV), the principle of using a real-time turbidimeter or lateral flow dipsticks for visualization of amplification products within 45 minutes is a paradigm that could be adapted for EHNV [7, 8]. For instance, a triplex LAMP assay for IHHNV achieved 100% sensitivity and specificity compared to qPCR, suggesting that a similar platform for EHNV could be developed to provide rapid, cost-effective, and field-deployable diagnostics [7]. The reverse-transcription cross-priming amplification-based lateral flow assay (RT-CPA-LFA) developed for IHNV, which visualizes amplification products on a dipstick within 5 minutes, further demonstrates the potential for ultra-rapid, user-friendly diagnostics that circumvent the need for complex laboratory equipment [8].

The integration of molecular detection with histopathological examination provides the most robust diagnostic framework. The WOAH-listed nature of EHNV necessitates that diagnosis is not based on molecular evidence alone, but is supported by observation of characteristic histopathology: multifocal necrosis in the hematopoietic tissues of the kidney and spleen, hepatocellular necrosis, and hepatic eosinophilic intracytoplasmic inclusion bodies [5]. A diagnosis of EHNV infection is most confidently made when viral genome is detected via PCR in tissues showing these pathognomonic lesions [5]. Therefore, a comprehensive diagnostic workflow should prioritize the collection of tissues (spleen, kidney, liver) for both molecular testing and histology. The high sensitivity of qPCR allows for the detection of subclinical infections or carrier states, but the presence of the genome does not always correlate with active disease; histopathology and viral load quantification are essential for confirming clinical significance. The continued refinement of these molecular and serological tools, coupled with a deep understanding of viral biology, remains the frontline defense against the spread of this economically devastating pathogen.

Antigenic Characterization and Immune Response to EHNV

The antigenic landscape of the Epizootic Hematopoietic Necrosis Virus (EHNV) remains one of the most critically underexplored domains within iridovirology, a knowledge gap that significantly hampers the development of effective immunoprophylactic strategies for this WOAH-listed pathogen. As a ranavirus within the family Iridoviridae, EHNV presents a unique challenge to the host immune system, characterized by a complex interplay between conformational epitopes, non-neutralizing antibody responses, and a multifaceted host antiviral program that spans both innate and adaptive arms. The following analysis synthesizes the available data on the molecular antigenic determinants of EHNV, the humoral and cellular immune responses elicited in susceptible salmonid hosts, and the implications for vaccine design and disease management.

Molecular Antigenic Determinants and the Major Capsid Protein

The foundational work on EHNV antigenic characterization was performed by Monini and Ruggeri [1], who produced a panel of murine monoclonal antibodies (MAbs) following parenteral inoculation with live virus. This study remains the most comprehensive attempt to map the antigenic topography of the virion. From 124 primary hybridoma cultures, a striking observation emerged: no neutralizing monoclonal antibodies were detected. This finding is of paramount importance, as it suggests that the immunodominant epitopes on the EHNV virion are either non-neutralizing or that the virus possesses sophisticated mechanisms to shield critical neutralization-sensitive sites. This contrasts sharply with other fish rhabdoviruses like IHNV, where the glycoprotein (G) is a potent target for neutralizing antibodies [10, 11, 23].

The study by Monini and Ruggeri [1] identified three distinct categories of antigenic targets:

1. The 50-kDa Major Capsid Protein (MCP): Three MAbs immunoprecipitated the MCP from infected cell lysates but failed to recognize it in Western blotting. This is a classic hallmark of conformation-dependent epitopes. The MCP, being the primary structural component of the icosahedral capsid, likely presents complex, three-dimensional antigenic surfaces that are denatured under reducing and SDS-denaturing conditions. This reliance on native conformation has profound implications for vaccine design; subunit vaccines based on linear MCP peptides may fail to elicit protective immunity, whereas properly folded, particulate MCP-based immunogens would be required to mimic these native epitopes.
2. Low Molecular Weight Peptides (15 and 18 kDa): Eight and five MAbs recognized peptides of approximately 15 and 18 kDa, respectively. These likely represent smaller structural proteins or proteolytic cleavage products of larger capsid components. Their role in protective immunity remains entirely unknown, but their immunogenicity in mice suggests they are exposed on the virion surface.
3. Unidentified Conformational Epitopes: Four MAbs could not be mapped to any specific viral protein by Western blotting or immunoprecipitation, yet they specifically immunostained infected cells and reacted with purified virions by ELISA. This strongly indicates that these antibodies recognize quaternary epitopes, structures formed by the assembly of multiple protein subunits, or complex glycosylation patterns that are destroyed during biochemical analysis.

The absence of neutralizing activity in this MAb panel [1] is a critical biological clue. It implies that the humoral immune response to EHNV, at least in a murine model, is dominated by antibodies that bind to the virus but do not block entry. This may be a strategy of immune evasion, where the virus presents a "decoy" of non-neutralizing epitopes to divert the host's B-cell response away from vulnerable sites on the fusion machinery or receptor-binding domains. This phenomenon is well-documented in other large DNA viruses, such as herpesviruses and poxviruses.

The Innate Immune Response: A Frontline of Antiviral Defense

In the absence of robust neutralizing antibodies, the host's survival against EHNV likely hinges on the rapid and potent activation of the innate immune system. While direct transcriptomic data for EHNV is limited, extensive studies on the closely related Infectious Hematopoietic Necrosis Virus (IHNV) in rainbow trout provide a robust framework for understanding the expected immune pathways. Given that both are acute, systemic pathogens targeting hematopoietic tissues, the immune mechanisms are likely highly conserved.

Pattern Recognition and Signaling Cascades: Upon EHNV infection, host cells detect viral pathogen-associated molecular patterns (PAMPs), likely including double-stranded RNA (dsRNA) produced during viral replication and DNA motifs. This triggers a cascade of signaling through several key pathways. Transcriptomic analyses of IHNV-infected rainbow trout tissues (spleen, head kidney, gill, liver, and intestine) consistently reveal the upregulation of critical pattern recognition receptors (PRRs) and downstream signaling molecules [15, 16, 18, 19]. Specifically, the Toll-like receptor (TLR) pathway (TLR3, TLR7, TLR8, MYD88), the RIG-I-like receptor (RLR) pathway (IFIH1/MDA5, DHX58/LGP2), and the NOD-like receptor (NLR) pathway are robustly activated [16, 19]. The upregulation of TRIM25, a ubiquitin ligase essential for RIG-I signaling, further underscores the importance of this axis [15, 16, 18].

The convergence of these pathways leads to the phosphorylation and nuclear translocation of Interferon Regulatory Factors (IRF3 and IRF7) , which are master transcription factors for type I interferons (IFN) [15, 16, 19]. The expression of irf3 and irf7 is consistently and significantly upregulated in multiple organs following IHNV challenge [15, 16, 19], and this is expected to be a hallmark of the anti-EHNV response.

The Interferon Response and Antiviral State: The induction of type I IFN is the central event in the antiviral innate response. This leads to the expression of hundreds of Interferon-Stimulated Genes (ISGs) that establish an antiviral state. Key ISGs consistently identified in IHNV models include Mx1 (a dynamin-like GTPase that traps viral nucleocapsids), Vig1/2 (viperin, which disrupts viral membrane formation), and ISG15 (a ubiquitin-like modifier) [12, 15, 18, 19, 23]. The expression of mx1 and vig genes is a reliable biomarker of a functional IFN response and is often used to evaluate vaccine efficacy [12, 23]. For instance, the self-assembling ferritin nanovaccine (FerritVac) against IHNV was shown to upregulate mx, vig1, ifit5, and isg-15 in host macrophages, demonstrating that a strong innate response is a prerequisite for protection [12].

Cellular and Humoral Innate Effectors: Beyond the IFN system, the innate response involves a suite of biochemical effectors. Studies on IHNV show significant changes in serum and tissue levels of alkaline phosphatase (AKP) , acid phosphatase (ACP) , total superoxide dismutase (T-SOD) , catalase (CAT) , lysozyme (LZM) , and malondialdehyde (MDA) [15, 19]. The initial decrease followed by a sharp increase in these enzymes (e.g., AKP, ACP, T-SOD peaking at 48 hours post-infection) reflects an initial consumption by oxidative stress followed by a compensatory upregulation as part of the acute phase response [15, 19]. These non-specific humoral factors play a role in limiting viral spread and clearing cellular debris.

The Adaptive Immune Response and the Challenge of Neutralization

The adaptive immune response to EHNV, as inferred from IHNV studies, is characterized by a robust cellular component and a humoral component that is often delayed and, in the case of EHNV, potentially non-neutralizing.

Humoral Immunity: In IHNV infection, the production of specific immunoglobulin M (IgM) is a key marker of the adaptive humoral response. DNA vaccines and inactivated vaccines against IHNV consistently induce specific IgM, and neutralizing antibody titers correlate with protection, particularly in the early phase post-vaccination [10, 20, 21, 23]. However, the duration of this humoral protection can be limited. A study on an adjuvanted inactivated IHNV vaccine showed that neutralizing antibodies were only detectable at 30 and 60 days post-vaccination, yet protection persisted for up to 285 days [20]. This suggests that long-term protection is not solely dependent on circulating neutralizing antibodies and may be mediated by other mechanisms, such as cellular immunity or trained immunity (innate immune memory) [17, 20].

The situation with EHNV is more concerning. The complete absence of neutralizing MAbs in the murine panel [1] raises the possibility that EHNV may be particularly adept at evading the neutralizing antibody response in its natural salmonid hosts. If the B-cell epitopes on the MCP are exclusively conformational and non-neutralizing, then traditional vaccine approaches designed to elicit high-titer neutralizing antibodies may fail. This would necessitate a shift towards vaccines that primarily induce potent cellular immunity.

Cellular Immunity: The cellular immune response, particularly CD8+ cytotoxic T lymphocytes (CTLs) , is critical for clearing cells infected with non-cytopathic or slowly cytopathic viruses. In IHNV models, the expression of genes related to T-cell activation and antigen presentation is upregulated. For example, the bivalent adenovirus-vectored vaccine against IHNV and IPNV induced upregulation of both innate and adaptive immune genes, including those associated with T-cell responses [21]. The study by Kim et al. [17] on cross-protection between VHSV and IHNV is particularly instructive. They found that a single-cycle VHSV vaccine (which cannot spread) provided cross-protection against IHNV, while a DNA vaccine did not. This protection was independent of neutralizing antibodies and was hypothesized to be mediated by trained immunity (epigenetic reprogramming of innate immune cells) rather than classical CTL cross-reactivity, as the number of shared CTL epitopes between the two viruses was deemed low [17]. This suggests that for ranaviruses like EHNV, which may not be efficiently neutralized by antibodies, the induction of trained immunity or robust CTL responses targeting conserved internal proteins (like the MCP) could be a more effective strategy.

Immune Evasion and Pathogenesis

EHNV, like other ranaviruses, likely employs several immune evasion strategies. The lack of neutralizing epitopes on the MCP [1] is a primary evasion mechanism. Furthermore, the virus can cause severe necrosis of hematopoietic tissues, directly destroying the cellular factories of the immune system (kidney and spleen) [5]. The transcriptomic data from IHNV infections reveal that virulent strains can drive pathogenesis by activating metabolic energy pathways for viral replication, facilitating necrosis through autophagy, and causing a shutoff of the host type I IFN response at the initial stage of infection [22]. The virus may also manipulate host microRNAs (miRNAs) to its advantage. For instance, IHNV upregulates host miR-146a-3p, which targets WNT3a and CCND1, thereby suppressing the type-I IFN response and promoting viral replication [13]. Conversely, host miR-206 can inhibit IHNV replication by targeting RIP2, a kinase involved in NF-κB and IFN signaling [14]. This delicate balance between pro-viral and anti-viral miRNAs is a key battleground in the host-virus arms race and is likely a feature of EHNV pathogenesis as well.

Implications for Vaccine Development and Diagnostics

The antigenic characterization of EHNV has direct and sobering implications for disease control:

1. Vaccine Design: The dominance of non-neutralizing, conformation-dependent epitopes on the MCP [1] suggests that inactivated whole-virus vaccines or virus-like particles (VLPs) that preserve the native capsid structure may be more effective than recombinant subunit vaccines based on linear peptides. The success of VLP-based approaches against IHHNV in shrimp, where VLPs induced peroxiredoxin expression and antiviral activity [24], supports this concept. However, even with a properly folded immunogen, the absence of a neutralizing antibody response may limit vaccine efficacy to reducing clinical signs rather than preventing infection and transmission, a problem already observed with IHNV vaccines [11].
2. Diagnostic Serology: The reliance on conformation-dependent epitopes complicates the development of simple, robust serological assays like linear peptide-based ELISAs. Diagnostic tests for EHNV must use native viral antigens (e.g., purified virions or infected cell lysates) to capture the full repertoire of antibodies present in convalescent fish. The development of MAbs that recognize these conformational epitopes [1] provides essential tools for antigen-capture ELISAs and immunohistochemistry.
3. Biosecurity and Surveillance: Given the lack of effective vaccines and the potential for non-neutralizing antibody responses, biosecurity remains the cornerstone of EHNV control. The virus is a WOAH-notifiable pathogen, and surveillance programs must rely on molecular detection (e.g., PCR targeting the MCP gene) rather than serology for early detection [4, 9]. The high genetic stability of EHNV compared to RNA viruses like IHNV [3] is a double-edged sword: it makes molecular diagnostics more reliable but also suggests that the virus's antigenic profile is stable, meaning that if a protective antigen is identified, it is less likely to escape vaccine-induced immunity through antigenic drift.

In conclusion, the antigenic characterization of EHNV reveals a virus that is immunologically elusive, with a capsid dominated by non-neutralizing conformational epitopes [1]. The host immune response, as modeled by IHNV, is a complex and dynamic process involving a robust but potentially insufficient innate response, a delayed and possibly non-neutralizing humoral response, and a critical but poorly understood cellular component [15-17, 19]. Future research must prioritize the identification of any neutralizing epitopes on EHNV, the elucidation of CTL epitopes, and the exploration of trained immunity as a novel avenue for vaccine development. Without a fundamental shift in our understanding of how the salmonid immune system recognizes and controls this ranavirus, the development of effective prophylactic measures against EHNV will remain a formidable challenge.

Current Strategies for Control and Prevention of EHNV Outbreaks

The containment and prevention of Epizootic Hematopoietic Necrosis Virus (EHNV) represents a formidable challenge in modern aquaculture and conservation fisheries management. As a pathogen listed by the World Organisation for Animal Health (WOAH), EHNV is subject to stringent international reporting requirements and biosecurity protocols; yet, the current armamentarium of control strategies remains decidedly limited compared to other notifiable viral pathogens of finfish [5, 6]. The fundamental difficulty lies in the virus's biology: EHNV is a highly stable iridovirus capable of persisting in aquatic environments, its target tissues are the very hematopoietic organs essential for fish immune function, and no specifically licensed commercial vaccine currently exists for this pathogen. Consequently, contemporary control strategies must rely upon a multi-pronged approach integrating rigorous biosecurity, advanced surveillance diagnostics, strategic stock management with exploitation of genetic resistance, and the judicious application of immunostimulatory compounds and experimental vaccine platforms adapted from closely related viral systems. This analysis dissects the current strategies, their biological underpinnings, and the critical gaps that render EHNV a persistent threat.

Biosecurity, Quarantine, and Movement Restrictions: The First Line of Defense

Given the absence of a licensed vaccine, biosecurity remains the most critical and effective strategy for EHNV control. The virus's notifiable status under WOAH mandates that any suspicion or confirmation of EHNV triggers immediate containment measures, including the imposition of movement restrictions on live fish, gametes, and equipment from affected facilities [5, 6]. The biological rationale for these stringent measures is compelling. EHNV is an exceptionally robust virus; its iridovirus structure confers environmental stability, allowing it to survive in water for extended periods and persist on fomites, including nets, tanks, and transport vehicles. This stability means that mechanical transmission via contaminated equipment, personnel, or甚至是 piscivorous birds cannot be discounted.

Effective biosecurity programs must therefore be comprehensive and hierarchically structured. At the facility level, this entails strict disinfection protocols for all equipment and footwear, the use of facility-specific tools, and the implementation of physical barriers to prevent ingress of potentially contaminated water or fomites. Source water management is paramount; farms must utilize water sources free from wild fish populations that could act as asymptomatic reservoirs. The experience with EHNV monitoring in regions like the Peruvian highlands, where surveillance of diseased rainbow trout found no EHNV DNA but revealed endemic bacterial pathogens such as Yersinia ruckeri and Aeromonas spp., underscores a critical lesson: biosecurity failures are often multifactorial [4]. It also highlights that EHNV can be present at undetectable (below 5% prevalence) or truly absent levels, and that clinical outbreaks assumed to be viral must be rigorously tested to avoid misdiagnosis and inappropriate control measures [4]. The core of any biosecurity plan must be the sourcing of fish from declared EHNV-free zones or hatcheries with documented health status, coupled with rigorous quarantine of all new introductions for a period sufficient to allow clinical signs to manifest and for sensitive diagnostic testing to be performed.

Diagnostic Surveillance: The Cornerstone of Detection and Containment

Rapid and accurate diagnosis is absolutely essential for effective control. Without it, silent spread can occur before clinical signs emerge, rendering biosecurity measures reactive rather than preventive. The current gold standard for EHNV detection involves nucleic acid amplification, specifically polymerase chain reaction (PCR) targeting the major capsid protein (MCP) gene, as recommended by WOAH [4, 5]. While highly sensitive and specific, conventional PCR requires well-equipped laboratories, trained personnel, and significant turnaround time, which can be a bottleneck for rapid on-farm decision-making. Histopathology, while useful for identifying characteristic lesions such as multifocal necrosis in the kidney, spleen, and liver, is not confirmatory on its own and must be integrated with molecular diagnostics [5].

Recognizing these limitations, the field is moving toward point-of-care and field-deployable diagnostic technologies. Drawing directly from platforms developed for other notifiable viral diseases affecting hematopoietic tissues, such as Infectious Hypodermal and Hematopoietic Necrosis Virus (IHHNV) in shrimp and Infectious Hematopoietic Necrosis Virus (IHNV) in salmonids, there is immense potential for adapting similar technologies for EHNV. For instance, real-time Loop-Mediated Isothermal Amplification (LAMP) assays developed for IHHNV achieve 100% sensitivity and specificity in under 45 minutes with a simple turbidimeter, eliminating the need for thermocyclers [7]. Similarly, Enzymatic Recombinase Amplification (ERA) assays for IHHNV demonstrate high sensitivity (as low as 1.4 × 10¹ copies/µL) at a constant temperature of 42°C within 20 minutes, processing samples faster than qPCR while maintaining robust specificity [29].

For salmonid viruses, Reverse-Transcription Cross-Priming Amplification-based Lateral Flow Assays (RT-CPA-LFA) have been validated for IHNV, providing visual detection of amplification products on a dipstick within 5 minutes, with diagnostic sensitivity and specificity exceeding 96% [8]. The development of a similar MCP-targeting LAMP or ERA assay for EHNV would be a revolutionary advance for control strategies. It would empower farm veterinarians and aquaculture personnel to perform on-site screening, enabling immediate quarantine and culling decisions without waiting for central laboratory confirmation. Furthermore, rapid genogrouping capability, analogous to the U/M multiplex RT-rPCR developed for IHNV in Pacific Northwest salmonids, would be invaluable for tracking EHNV strain emergence and spread across geographic regions, informing targeted control measures [9]. The paucity of such validated, field-robust tests for EHNV represents a critical void in the current control toolkit. Until such technologies are developed and commercially available, control programs must rely on a "test and cull" approach using more centralized diagnostics, which is often too slow to prevent rapid intra-farm and inter-farm transmission.

Vaccination Strategies: Bridging the Gap from Research Models

No commercial vaccine is licensed specifically for EHNV. This is the single greatest vulnerability in the current control strategy. However, substantial progress has been made in developing vaccine platforms against the closely related IHNV, and these strategies provide a logical and promising roadmap for EHNV vaccine development. The challenge is that the immunological requirements for an effective vaccine against an iridovirus like EHNV may differ from those for a rhabdovirus like IHNV. Early research on EHNV antigenic determinants revealed that monoclonal antibodies raised against the virus primarily recognized conformation-dependent epitopes, and critically, no neutralizing monoclonal antibodies were detected [1]. This suggests that humoral immunity alone may be insufficient for protection, and that a successful vaccine must robustly stimulate cell-mediated and innate immune pathways.

Inactivated and Adjuvanted Vaccines: For IHNV, the development of a formaldehyde-inactivated vaccine supplemented with the water-based adjuvant Montanide GEL 02 PR has shown remarkable promise, providing a Relative Percent Survival (RPS) of 89-100% within 2 months and extending protection to at least 285 days post-vaccination [20]. This is a significant breakthrough, as inactivated vaccines often provide only short-term protection. The mechanism of long-term protection in this model was not solely dependent on neutralizing antibodies, suggesting a role for trained innate immunity or cellular immune memory [20]. Extrapolating this to EHNV, an inactivated whole-virus vaccine adjuvanted with a similar polymer gel matrix could be a highly viable first-generation candidate. The major advantage is safety, no risk of reversion to virulence, but the major hurdles are the production of large quantities of EHNV antigen in cell culture and the need for injection-based delivery, which is labor-intensive and stressful for fry.

DNA Vaccines: DNA vaccines, particularly those encoding the glycoprotein (G) of IHNV, have been extensively studied and are the only commercialized IHN vaccine in some regions. They induce potent innate and adaptive immune responses, including upregulation of interferon-related genes (e.g., mx-1, ifn-1) and specific antibodies [10, 11, 23]. However, their application to EHNV faces a fundamental biological hurdle: the sequence of the EHNV major capsid protein or other immunogenic targets must be identified and shown to elicit a protective response. Moreover, DNA vaccines against IHNV have shown significant protection against mortality but limited protection against viral shedding and transmission [11]. This is a critical epidemiological point. If a future EHNV DNA vaccine protects individual fish from death but does not reduce shedding, it will fail to reduce the force of infection within a population, and outbreaks could still propagate, albeit with lower mortality. The self-assembling ferritin nanoplatform (FerritVac) developed for IHNV offers another innovative approach, providing a stable, oral-deliverable subunit vaccine that induces antiviral gene markers (mx, vig1, ifit5, isg-15) [12]. This platform could theoretically be adapted to display EHNV epitopes, enabling oral mass vaccination of fry.

Recombinant and Viral-Vectored Vaccines: The development of bivalent recombinant adenovirus-vectored vaccines co-expressing IHNV G and IPNV VP2 proteins has shown high protection (RPS 78-81%) via immersion, a stress-free and scalable route [21]. This demonstration that a replication-defective adenovirus can function as an effective vector for fish vaccines opens the door for an EHNV-targeted adenovirus vaccine. Furthermore, reverse genetics has allowed for the creation of attenuated IHNV strains with mutations in the N protein that reduce virulence while retaining immunogenicity, offering a path toward live-attenuated vaccines [32]. However, safety concerns regarding reversion and environmental persistence of a live iridovirus make this a less attractive option for EHNV.

Intrinsic and Acquired Antiviral Mechanisms: There is also growing interest in harnessing the host's own antiviral machinery. Research on IHNV has identified numerous microRNAs (miRNAs) that modulate the interferon pathway and viral replication. For example, miR-206 targets RIP2 to inhibit IHNV replication, while miR-146a-3p promotes IHNV replication by suppressing the type-I IFN response [13, 14]. Intervention strategies using miRNA mimics or inhibitors could potentially be developed as antiviral therapeutics for EHNV, though this remains a nascent field. Similarly, the identification of DDX3, a DEAD-box RNA helicase, as a host factor that inhibits IHNV replication suggests that targeting such broadly conserved antiviral effectors could be a strategy applicable to EHNV [33].

Immunostimulants and Nutritional Interventions: A Supportive Role

In the absence of a vaccine, dietary immunostimulation represents a practical, low-cost strategy to enhance resistance against EHNV. Empirical evidence from IHNV research strongly supports the potential of such an approach. Dietary supplementation with Chinese herbal medicine mixtures (CHMMs), including Astragalus polysaccharides (APS), crude lentinan (CLNT), and bufalin, has demonstrated significant antiviral activity in rainbow trout [25-27, 31]. These compounds upregulate key immune parameters (T-SOD, CAT, ACP, AKP), activate the interferon signaling pathway, and downregulate pro-inflammatory cytokines, ultimately reducing IHNV viral loads and mortality [25, 26]. Specifically, APS enhanced the efficacy of an inactivated IHNV vaccine by promoting immune cell activation and inhibiting viral replication in the spleen [25]. Crude lentinan strengthened the intestinal immune barrier and modified the gut microbiota, promoting the growth of short-chain fatty acid-producing bacteria and reducing IHNV-induced mortality [31].

For EHNV, these findings are highly translatable. A prophylactic feeding regimen incorporating a standardized immunostimulant could be deployed during high-risk periods (e.g., spring temperature increases or after handling stress) to elevate the general resistance of the population. This is not a curative measure, but a management tool that can reduce the force of infection and delay or prevent the establishment of an epizootic. The interplay between water temperature and immunocompetence is also critical. Research on IHNV in rainbow trout at different culture temperatures (12-13°C vs. 16-17°C) demonstrated that higher temperatures significantly altered the gut microbiota and immune-metabolomic profile, with beneficial bacteria like Lactococcus lactis proliferating at higher temperatures, potentially offering some protection [30]. Thus, environmental temperature management could be incorporated into EHNV control strategies, although the optimal temperature for host defense versus viral replication must be carefully balanced. Furthermore, the selection of broodstock with genetic resistance, even if purely based on estimated breeding values from oligogenic QTLs, can complement nutritional strategies to build a more resilient stock [28].

Path to a Comprehensive Control Framework

The current strategies for controlling EHNV are reactive, relying on detection and culling, rather than proactive prevention. To advance the field, a coordinated research and implementation agenda is required. First, the development and validation of a rapid, field-deployable LAMP or ERA assay for EHNV is the most urgent diagnostic need. Second, vaccine development must pivot from model systems to EHNV-specific candidates. The inactivated adjuvanted vaccine strategy validated for IHNV, utilizing the Montanide GEL 02 PR adjuvant, should be prioritized for testing against EHNV [20]. The recombinant adenovirus platform offers a scalable, immersion-deliverable option that warrants immediate investigation [21]. Third, a systematic study of the efficacy of selected immunostimulants (e.g., APS, lentinan) against EHNV in controlled challenge experiments is necessary to provide an evidence base for their use [25, 26, 31]. Finally, the integration of genomic selection for resistance, updated biosecurity protocols informed by risk analysis, and strategic temperature management should form the backbone of a modern, preventive control strategy. The WOAH framework provides the regulatory teeth, but it is the scientific community that must provide the tools. Without a concerted effort to develop EHNV-specific vaccines and field-deployable diagnostics, the industry will remain vulnerable to the significant economic and ecological damage this resilient pathogen can inflict.

References

[1] Monini M, Ruggeri F. Antigenic peptides of the epizootic hematopoietic necrosis virus.. Virology. 2002. DOI: https://doi.org/10.1006/VIRO.2002.1410

[2] Alinejad T, Bin KQ, Vejayan J, Othman RY, Bhassu S. Proteomic analysis of differentially expressed protein in hemocytes of wild giant freshwater prawn Macrobrachium rosenbergii infected with infectious hypodermal and hematopoietic necrosis virus (IHHNV). Meta Gene. 2015. DOI: https://doi.org/10.1016/j.mgene.2015.05.004

[3] Robles-Sikisaka R, Bohonak A, Mcclenaghan L, Dhar A. Genetic Signature of Rapid IHHNV (Infectious Hypodermal and Hematopoietic Necrosis Virus) Expansion in Wild Penaeus Shrimp Populations. PLoS ONE. 2010. DOI: https://doi.org/10.1371/journal.pone.0011799

[4] KarenBautista D, AlbertoManchego S, GinaCastro S, NievesSandoval C. Ausencia del virus de Necrosis Hematopoyética Epizoótica (EHNv) en truchas arcoíris (Oncorhynchus mykiss) enfermas en piscigranjas de la sierra del Perú. . 2018. DOI: https://doi.org/10.15381/RIVEP.V29I3.14841

[5] Kurapati Rb, Ramena G, Wanjala H, Gudapati S, Ramena Y. Viral Disease Histopathology in Aquaculture Finfish: Organ‐Specific Pathological Changes and Diagnostic Insights, Referencing the World Organisation for Animal Health: A Review. Reviews in Aquaculture. 2026. DOI: https://doi.org/10.1111/raq.70129

[6] . infectious hypodermal and hematopoietic necrosis virus. CABI Compendium. 2022. DOI: https://doi.org/10.1079/cabicompendium.96201

[7] Arunrut N, Jitrakorn S, Tondee B, Saksmerprome V, Kiatpathomchai W. Real-time triplex loop-mediated isothermal amplification (LAMP) using a turbidimeter for detection of shrimp infectious hypodermal and hematopoietic necrosis virus (IHHNV).. Journal of Aquatic Animal Health. 2024. DOI: https://doi.org/10.1002/aah.10218

[8] Choi HD, Baek E, Hong S, Kim YC, Jeong J, Kwon M, et al.. Development and validation of reverse-transcription cross-priming amplification-based lateral flow assay for the detection of infectious hematopoietic necrosis virus.. Journal of Virological Methods. 2024. DOI: https://doi.org/10.1016/j.jviromet.2024.115008

[9] Batts W, Capps TR, Crosson LM, Powers RL, Breyta R, Purcell M. Rapid Diagnostic Test to Detect and Discriminate Infectious Hematopoietic Necrosis Virus (IHNV) Genogroups U and M to Aid Management of Pacific Northwest Salmonid Populations. Animals. 2022. DOI: https://doi.org/10.3390/ani12141761

[10] Jalali SAH, nia Ss, Kashkooli OB, Soleimanin-Zad S. Oral immunization with attenuated Salmonella Typhimurium as a carrier of DNA vaccine against infectious hematopoietic necrosis virus (IHNV) in rainbow trout (Oncorrhynchus mykiss).. Fish and Shellfish Immunology. 2025. DOI: https://doi.org/10.1016/j.fsi.2025.110127

[11] Doumayrou J, Frazier MG, Brown H, Wargo A. Efficacy of Three Vaccine Regimens Against Infectious Hematopoietic Necrosis Virus Transmission Potential in Rainbow Trout. Vaccines. 2025. DOI: https://doi.org/10.3390/vaccines13080864

[12] Ahmadivand S, Krpetić Ž, Martínez MM, Garcia-Ordoñez M, Roher N, Palić D. Self-assembling ferritin nanoplatform for the development of infectious hematopoietic necrosis virus vaccine. Frontiers in Immunology. 2024. DOI: https://doi.org/10.3389/fimmu.2024.1346512

[13] Huang J, Zheng S, Li Q, Zhao H, Zhou X, Yang Y, et al.. Host miR-146a-3p Facilitates Replication of Infectious Hematopoietic Necrosis Virus by Targeting WNT3a and CCND1. Veterinary Sciences. 2024. DOI: https://doi.org/10.3390/vetsci11050204

[14] Wu S, Huang J, Li Y. Antiviral effect of miR-206 in rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus infection.. Fish and Shellfish Immunology. 2024. DOI: https://doi.org/10.1016/j.fsi.2024.109552

[15] Zhao L, Huang J, Li Y, Wu S, Kang Y. Comprehensive analysis of immune parameters, mRNA and miRNA profiles, and immune genes expression in the gill of rainbow trout infected with infectious hematopoietic necrosis virus (IHNV).. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.108546

[16] Sun T, Huang J, Li Y, Wu S, Zhao L, Kang Y. Integrative mRNA-miRNA interaction analysis associated with the immune response in the head kidney of rainbow trout (Oncorhynchus mykiss) after infectious hematopoietic necrosis virus infection.. Fish and Shellfish Immunology. 2023. DOI: https://doi.org/10.1016/j.fsi.2023.109140

[17] Kim SY, Lee KM, Kim KH. Differences between DNA vaccine and single-cycle viral vaccine in the ability of cross-protection against viral hemorrhagic septicemia virus (VHSV) and infectious hematopoietic necrosis virus (IHNV).. Vaccine. 2023. DOI: https://doi.org/10.1016/j.vaccine.2023.07.058

[18] Zhao L, Huang J, Wu S, Li Y, Pan Y. Integrative analysis of miRNA and mRNA expression associated with the immune response in the intestine of rainbow trout (Oncorhynchus mykiss) infected with infectious hematopoietic necrosis virus.. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.09.039

[19] Wu S, Huang J, Li Y, Lei M, Zhao L, Liu Z. Integrated analysis of immune parameters, miRNA-mRNA interaction, and immune genes expression in the liver of rainbow trout following infectious hematopoietic necrosis virus infection. Frontiers in Immunology. 2022. DOI: https://doi.org/10.3389/fimmu.2022.970321

[20] Lin Y, Ren G, Zhao J, Shao Y, He B, Tang X, et al.. Long-Term Protection Elicited by an Inactivated Vaccine Supplemented with a Water-Based Adjuvant against Infectious Hematopoietic Necrosis Virus in Rainbow Trout (Oncorhynchus mykiss). Microbiology spectrum. 2022. DOI: https://doi.org/10.1128/spectrum.03245-22

[21] Li S, Li X, Yuan R, Chen X, Chen S, Qiu Y, et al.. Development of a recombinant adenovirus-vectored vaccine against both infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss).. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.108457

[22] Kim J, Cho M, Lim J, Choi H, Hong S. Pathogenic Mechanism of a Highly Virulent Infectious Hematopoietic Necrosis Virus in Head Kidney of Rainbow Trout (Oncorhynchus mykiss) Analyzed by RNA-Seq Transcriptome Profiling. Viruses. 2022. DOI: https://doi.org/10.3390/v14050859

[23] Huo C, Huang D, Ma Z, Li G, Li T, Lin W, et al.. Specificity of DNA Vaccines against the Genogroup J and U Infectious Hematopoietic Necrosis Virus Strains Prevalent in China. Viruses. 2022. DOI: https://doi.org/10.3390/v14122707

[24] Weerachatyanukul W, Pooljun C, Hirono I, Kondo H, Chotwiwatthanakun C, Jariyapong P. Infectious hypodermal and hematopoietic necrosis virus-like particle (IHHNV-VLP) induces peroxiredoxin expression and activity in Fenneropenaeus merguiensis.. Fish and Shellfish Immunology. 2021. DOI: https://doi.org/10.1016/j.fsi.2021.12.015

[25] Pan Y, Liu Z, Lu J, Quan J, Zhao G, Song G, et al.. Astragalus polysaccharide inhibits infectious hematopoietic necrosis virus damage to rainbow trout (Oncorhynchus mykiss) spleen by promoting the efficacy of inactivated vaccine.. Fish and Shellfish Immunology. 2025. DOI: https://doi.org/10.1016/j.fsi.2025.110180

[26] Wang Q, Pan Y, Huang J, Li Y, Wu S, Zhao L, et al.. Dietary supplementation of Chinese herbal medicines enhances the immune response and resistance of rainbow trout (Oncorhynchus mykiss) to infectious hematopoietic necrosis virus. Frontiers in Veterinary Science. 2024. DOI: https://doi.org/10.3389/fvets.2024.1341920

[27] Zhao J, Xu L, Li L, Ren G, Shao Y, Liu Q, et al.. Traditional Chinese medicine bufalin inhibits infectious hematopoietic necrosis virus infection in vitro and in vivo. Microbiology spectrum. 2024. DOI: https://doi.org/10.1128/spectrum.05016-22

[28] Palti Y, Vallejo R, Purcell MK, Gao G, Shewbridge KL, Long R, et al.. Genome-wide association analysis of the resistance to infectious hematopoietic necrosis virus in two rainbow trout aquaculture lines confirms oligogenic architecture with several moderate effect quantitative trait loci. Frontiers in Genetics. 2024. DOI: https://doi.org/10.3389/fgene.2024.1394656

[29] Zhang L, Liu K, Liu M, Hu J, Bao Z, Wang M. Development of a real-time enzymatic recombinase amplification assay for rapid detection of infectious hypodermal and hematopoietic necrosis virus (IHHNV) in shrimp Penaeus vannamei.. Journal of Invertebrate Pathology. 2023. DOI: https://doi.org/10.1016/j.jip.2023.108024

[30] Hai Q, Wang J, Kang W, Cheng S, Li J, Lyu N, et al.. Metagenomic and metabolomic analysis of changes in intestinal contents of rainbow trout (Oncorhynchus mykiss) infected with infectious hematopoietic necrosis virus at different culture water temperatures. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1275649

[31] Ren G, Xu L, Zhao J, Shao Y, Chen X, Lu T, et al.. Supplementation of Dietary Crude Lentinan Improves the Intestinal Microbiota and Immune Barrier in Rainbow Trout (Oncorhynchus mykiss) Infected by Infectious Hematopoietic Necrosis Virus. Frontiers in Immunology. 2022. DOI: https://doi.org/10.3389/fimmu.2022.920065

[32] Li J, Xia D, Zhang M, Zhang Y, Liu X, Sun J, et al.. Infectious hematopoietic necrosis virus (IHNV) nucleoprotein amino acid residues affect viral virulence and immunogenicity in rainbow trout (Oncorhynchus mykiss).. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.08.028

[33] Zhao J, Xu L, Ren G, Shao Y, Lu T. Identification and characterization of DEAD-box RNA helicase DDX3 in rainbow trout (Oncorhynchus mykiss) and its relationship with infectious hematopoietic necrosis virus infection.. Developmental and Comparative Immunology. 2022. DOI: https://doi.org/10.1016/j.dci.2022.104493